NovoCure Limited Increase (Decrease) in Other Noncurrent Liabilities
NovoCure Limited (NVCR) reported Increase (Decrease) in Other Noncurrent Liabilities of -$2.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-07-23
- NovoCure Limited increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was -$2.79M, a 403.15% decline year-over-year.
- NovoCure Limited increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was -$2.84M.
- NovoCure Limited increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$2.64M.
- NovoCure Limited increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was -$2.43M.
- NovoCure Limited increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$6.36M.
- NovoCure Limited increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$9.78M.
- NovoCure Limited increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$7.77M.
- NovoCure Limited increase (decrease) in other noncurrent liabilities for fiscal 2021 was -$10.98M, a 1753.61% decline from fiscal 2020.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 3 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 12 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.79M 10-Q · filed 2026-07-23 | -$5.63M 10-Q · filed 2026-07-23 | -$8.27M derived: sum of 3 quarters · filed 2026-07-23 | -$10.70M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-31 | -$2.84M 10-Q · filed 2026-04-30 | -$5.48M derived: sum of 2 quarters · filed 2026-07-23 | -$7.91M derived: sum of 3 quarters · filed 2026-07-23 | -$6.99M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-31 | -$2.64M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-23 | -$5.07M derived: sum of 2 quarters · filed 2026-07-23 | -$4.15M derived: sum of 3 quarters · filed 2026-07-23 | -$5.27M 10-Q · filed 2026-07-23 | ||||
| 2025-09-30 | -$2.43M 10-Q · filed 2025-10-30 | -$1.51M derived: sum of 2 quarters · filed 2026-07-23 | -$2.63M 10-Q · filed 2025-10-30 | -$3.86M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-30 | $920.00K 10-Q · filed 2026-07-23 | -$201.00K 10-Q · filed 2026-07-23 | -$1.43M derived: sum of 3 quarters · filed 2026-07-23 | -$2.97M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-31 | -$1.12M 10-Q · filed 2026-04-30 | -$2.35M derived: sum of 2 quarters · filed 2026-04-30 | -$3.89M derived: sum of 3 quarters · filed 2026-04-30 | -$5.72M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.77M derived: sum of 2 quarters · filed 2026-02-26 | -$4.59M derived: sum of 3 quarters · filed 2026-02-26 | -$6.36M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$1.54M 10-Q · filed 2025-10-30 | -$3.37M derived: sum of 2 quarters · filed 2025-10-30 | -$5.13M 10-Q · filed 2025-10-30 | -$6.98M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$1.83M 10-Q · filed 2025-07-24 | -$3.59M 10-Q · filed 2025-07-24 | -$5.44M derived: sum of 3 quarters · filed 2026-02-26 | -$8.52M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$1.76M 10-Q · filed 2025-04-24 | -$3.61M derived: sum of 2 quarters · filed 2026-02-26 | -$6.69M derived: sum of 3 quarters · filed 2026-02-26 | -$8.39M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.92M derived: sum of 2 quarters · filed 2026-02-26 | -$6.62M derived: sum of 3 quarters · filed 2026-02-26 | -$9.78M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$3.08M 10-Q · filed 2024-10-30 | -$4.78M derived: sum of 2 quarters · filed 2024-10-30 | -$7.93M 10-Q · filed 2024-10-30 | -$9.60M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$1.70M 10-Q · filed 2024-07-25 | -$4.86M 10-Q · filed 2024-07-25 | -$6.53M derived: sum of 3 quarters · filed 2025-02-27 | -$8.15M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$3.16M 10-Q · filed 2024-05-02 | -$4.83M derived: sum of 2 quarters · filed 2025-02-27 | -$6.45M derived: sum of 3 quarters · filed 2025-02-27 | -$8.60M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$3.30M derived: sum of 2 quarters · filed 2025-02-27 | -$5.44M derived: sum of 3 quarters · filed 2025-02-27 | -$7.77M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | -$1.63M 10-Q · filed 2023-10-26 | -$3.77M derived: sum of 2 quarters · filed 2023-10-26 | -$6.10M 10-Q · filed 2023-10-26 | -$8.32M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | -$2.14M 10-Q · filed 2023-07-27 | -$4.47M 10-Q · filed 2023-07-27 | -$6.70M derived: sum of 3 quarters · filed 2024-02-22 | -$8.64M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | -$2.33M 10-Q · filed 2023-05-04 | -$4.55M derived: sum of 2 quarters · filed 2024-02-22 | -$6.50M derived: sum of 3 quarters · filed 2024-02-22 | -$8.92M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | -$2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$4.17M derived: sum of 2 quarters · filed 2024-02-22 | -$6.59M derived: sum of 3 quarters · filed 2024-02-22 | -$10.98M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | -$1.95M 10-Q · filed 2022-10-27 | -$4.36M derived: sum of 2 quarters · filed 2022-10-27 | -$8.76M 10-Q · filed 2022-10-27 | -$8.51M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | -$2.42M 10-Q · filed 2022-07-28 | -$6.81M 10-Q · filed 2022-07-28 | -$6.56M derived: sum of 3 quarters · filed 2023-02-23 | -$4.66M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | -$4.39M 10-Q · filed 2022-04-28 | -$4.14M derived: sum of 2 quarters · filed 2023-02-23 | -$2.24M derived: sum of 3 quarters · filed 2023-02-23 | -$3.50M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.16M derived: sum of 2 quarters · filed 2023-02-23 | $890.00K derived: sum of 3 quarters · filed 2023-02-23 | $664.00K 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $1.91M 10-Q · filed 2021-10-28 | $639.00K derived: sum of 2 quarters · filed 2021-10-28 | $413.00K 10-Q · filed 2021-10-28 | -$2.30M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$1.27M 10-Q · filed 2021-07-29 | -$1.49M 10-Q · filed 2021-07-29 | -$4.21M derived: sum of 3 quarters · filed 2022-02-24 | -$5.61M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$225.00K 10-Q · filed 2021-04-29 | -$2.94M derived: sum of 2 quarters · filed 2022-02-24 | -$4.35M derived: sum of 3 quarters · filed 2022-02-24 | -$5.45M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$4.12M derived: sum of 2 quarters · filed 2022-02-24 | -$5.22M derived: sum of 3 quarters · filed 2022-02-24 | -$7.01M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$1.41M 10-Q · filed 2020-10-29 | -$2.51M derived: sum of 2 quarters · filed 2020-10-29 | -$4.29M 10-Q · filed 2020-10-29 | $5.87M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$1.10M 10-Q/A · filed 2020-10-02 | -$579.00K 10-Q · filed 2019-07-25 | -$2.88M 10-Q/A · filed 2020-10-02 | -$1.83M 10-Q · filed 2019-07-25 | $7.27M derived: sum of 3 quarters · filed 2021-02-25 | $7.36M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | -$1.78M 10-Q/A · filed 2020-10-02 | -$1.25M 10-Q · filed 2019-05-02 | $8.38M derived: sum of 2 quarters · filed 2021-02-25 | $8.46M derived: sum of 3 quarters · filed 2021-02-25 | $8.45M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $10.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $10.24M derived: sum of 2 quarters · filed 2021-02-25 | $10.23M derived: sum of 3 quarters · filed 2021-02-25 | $9.50M 10-K · filed 2021-02-25 | $9.37M 10-K · filed 2019-02-28 | |||
| 2018-09-30 | $83.00K 10-Q · filed 2019-10-31 | $52.00K 10-Q · filed 2018-10-25 | $67.00K derived: sum of 2 quarters · filed 2019-10-31 | -$656.00K 10-Q · filed 2019-10-31 | -$764.00K 10-Q · filed 2018-10-25 | -$3.60M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-06-30 | -$16.00K 10-Q · filed 2019-07-25 | -$816.00K 10-Q · filed 2019-07-25 | -$3.68M derived: sum of 3 quarters · filed 2020-02-27 | -$3.48M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$800.00K 10-Q · filed 2019-05-02 | -$3.67M derived: sum of 2 quarters · filed 2020-02-27 | -$3.46M derived: sum of 3 quarters · filed 2020-02-27 | -$3.14M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$2.66M derived: sum of 2 quarters · filed 2020-02-27 | -$2.34M derived: sum of 3 quarters · filed 2020-02-27 | -$1.79M 10-K · filed 2020-02-27 | -$2.23M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $208.00K 10-Q · filed 2018-10-25 | $529.00K derived: sum of 2 quarters · filed 2018-10-25 | $1.08M 10-Q · filed 2018-10-25 | $1.14M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $321.00K 10-Q · filed 2018-07-26 | $870.00K 10-Q · filed 2018-07-26 | $871.00K 10-Q · filed 2017-07-27 | $927.00K derived: sum of 3 quarters · filed 2019-02-28 | $1.19M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $550.00K 10-Q · filed 2018-04-26 | $606.00K derived: sum of 2 quarters · filed 2019-02-28 | $869.00K derived: sum of 3 quarters · filed 2019-02-28 | $1.09M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $319.00K derived: sum of 2 quarters · filed 2019-02-28 | $544.00K derived: sum of 3 quarters · filed 2019-02-28 | $957.00K 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $263.00K 10-Q · filed 2017-10-26 | $488.00K derived: sum of 2 quarters · filed 2017-10-26 | $901.00K 10-Q · filed 2017-10-26 | $1.80M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $225.00K 10-Q · filed 2017-07-27 | $638.00K 10-Q · filed 2017-07-27 | $1.54M derived: sum of 3 quarters · filed 2018-02-22 | $1.97M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $413.00K 10-Q · filed 2017-04-27 | $1.32M derived: sum of 2 quarters · filed 2018-02-22 | $1.75M derived: sum of 3 quarters · filed 2018-02-22 | $948.00K derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $904.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $1.33M derived: sum of 2 quarters · filed 2018-02-22 | $535.00K derived: sum of 3 quarters · filed 2018-02-22 | $581.00K 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $430.00K 10-Q · filed 2016-11-02 | -$369.00K derived: sum of 2 quarters · filed 2016-11-02 | -$323.00K 10-Q · filed 2016-11-02 | $382.00K derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | -$799.00K 10-Q · filed 2016-07-28 | -$753.00K 10-Q · filed 2016-07-28 | -$48.00K derived: sum of 3 quarters · filed 2017-02-23 | |||||
| 2015-03-31 | $46.00K 10-Q · filed 2016-05-10 | $751.00K derived: sum of 2 quarters · filed 2017-02-23 | ||||||
| 2014-12-31 | $705.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $764.00K 10-K · filed 2017-02-23 | ||||||
| 2014-09-30 | $59.00K 10-Q · filed 2015-10-27 | |||||||
| 2013-12-31 | $302.00K 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |